Probe into Carlo Croce reached “defensible and reasonable” decisions, says external review

An independent analysis of how The Ohio State University reviewed allegations of misconduct against a high-profile cancer researcher has found that the institution “complied with applicable law and with relevant institutional policies and reached reasoned and supportable conclusions.” The review follows numerous allegations of research misconduct against Carlo Croce, described in a March 8 story … Continue reading Probe into Carlo Croce reached “defensible and reasonable” decisions, says external review

Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct

Carlo Croce, a cancer researcher who has faced numerous research misconduct allegations, recently accused a former lab member of misconduct. Although an institutional probe did not support that allegation, Croce’s efforts have led to a retraction. In November 2015, Croce and another cancer researcher at Ohio State University (OSU), Ramiro Garzon, contacted PLOS ONE, alleging … Continue reading Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct

Carlo Croce, Ohio State researcher facing misconduct allegations, suing New York Times for defamation

Carlo Croce, a cancer researcher at The Ohio State University who has faced numerous allegations of research misconduct, has filed a lawsuit against the New York Times, claiming the newspaper defamed him in a March 8 story. Croce filed the civil suit May 10, in the US District Court for the Southern District of Ohio, … Continue reading Carlo Croce, Ohio State researcher facing misconduct allegations, suing New York Times for defamation

Carlo Croce, OSU cancer researcher under investigation, retracts paper

A researcher whose work has come under repeated scrutiny has retracted a 2008 paper for “errors that occurred in the construction” of various figures. Carlo Croce, the corresponding author of the newly retracted paper, has been dogged by misconduct accusations for years — as recently described in the New York Times. His employer, The Ohio … Continue reading Carlo Croce, OSU cancer researcher under investigation, retracts paper

Cancer biologist retracts five papers

A cancer researcher based at The Ohio State University has retracted five papers from one journal, citing concerns about figures. The notices for all five papers state the Journal of Biological Chemistry raised questions about some figures, and the authors were not able to supply raw data in all instances. Four of the notices say … Continue reading Cancer biologist retracts five papers

Retraction count for Italian researcher swells to 15 as five papers fall

A researcher who is facing a criminal investigation in Italy for research misconduct has seen five more papers retracted, for a total of 16 15. Molecular and Cellular Biology has retracted four papers published between 1987 to 2001 by Alfredo Fusco, a cancer researcher in Italy; the Journal of Virology retracted one 1985 paper. Fusco was … Continue reading Retraction count for Italian researcher swells to 15 as five papers fall

Cancer researcher under cloud of suspicion wins $300,000 science prize

Carlo Croce, who has had numerous papers retracted and corrected for issues including image manipulation, has received an award for more than $300,000 for his achievements in personalized medicine. The Dan David Prize, awarded earlier this month by a charitable organization based at Tel Aviv University, bestowed $1 million to three researchers who have “made pioneering … Continue reading Cancer researcher under cloud of suspicion wins $300,000 science prize

“My dog ate the data:” Eight excuses journal editors hear

As a journal editor, are you tired of hearing the same excuses from authors who are facing allegations of problematic data? If so, you’re not alone. Recently, an editor of the journal Oncogene co-authored an editorial in the journal listing the types of excuses he often hears — and why none of them is valid. … Continue reading “My dog ate the data:” Eight excuses journal editors hear

Division director leaving U.S. research watchdog after nearly 15 years

The director of the Division of Investigative Oversight at the U.S. Office of Research Integrity is leaving the agency. Susan Garfinkel told Retraction Watch that her last day is November 10. She is taking a position as assistant vice president in the Office of Research Compliance at The Ohio State University (OSU). Garfinkel declined to … Continue reading Division director leaving U.S. research watchdog after nearly 15 years

Weekend reads: Suicide after misconduct; taxonomic vandalism; a disastrous Nature editorial

The week at Retraction Watch featured a battle over psychologists and torture, a case of misconduct at Harvard, allegations of bribery, and a lawsuit against the New York Times. Here’s what was happening elsewhere: